Twist Bioscience Corporation
TWST
$47.66
-$1.98-3.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.41% | -233.09% | 151.85% | -24.48% | 8.83% |
| Total Depreciation and Amortization | 89.88% | -48.82% | -5.29% | 5.33% | 49.90% |
| Total Amortization of Deferred Charges | -89.66% | -- | -- | -- | -88.46% |
| Total Other Non-Cash Items | -20.65% | 151.53% | -249.53% | 76.75% | -13.37% |
| Change in Net Operating Assets | -92.44% | -284.59% | 409.83% | 85.08% | -617.98% |
| Cash from Operations | -110.04% | -743.86% | 89.22% | 39.40% | -39.87% |
| Capital Expenditure | 19.74% | -35.59% | -121.16% | -82.72% | -13.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -100.00% | -- | -- | -- |
| Other Investing Activities | 70.83% | 100.88% | -200.52% | 271.31% | 2.09% |
| Cash from Investing | 19.91% | -31.99% | -558.98% | 7.16% | -19.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.62% | 204.87% | -42.86% | 8.51% | -18.84% |
| Repurchase of Common Stock | 0.00% | 33.33% | 40.00% | 16.67% | 25.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | -94.65% | 205.26% | -42.87% | -82.19% | 394.73% |
| Foreign Exchange rate Adjustments | -94.48% | 329.58% | -168.27% | 296.23% | -172.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -86.36% | -104.38% | 18.63% | -119.04% | 60.69% |